Trademark: 88346102
Status Date
Monday, November 27, 2023
Filing Date
Tuesday, March 19, 2019
Published for Opposition
Tuesday, September 1, 2020
Abandoned Date
Monday, November 27, 2023
41 Educational services, namely, conducting classes, seminars, conferences and workshops in the field of medicine and pharmaceuticals related to the treatment of central nervous system diseases and disorders; providing training in the field of medicine; educational services, namely, conducting programs in the field of medicine and training services featuring diagnostic, medical and clinical guidance, health and medicine content through websites, social media platforms and mobile applications
9 Downloadable computer application software for mobile application for providing information on health, healthcare and medicine; downloadable software in the nature of a mobile application for facilitating communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical, and health fields; downloadable mobile application for providing information on health, healthcare and medicine; downloadable software in the nature of a mobile application for facilitating communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical, and healthcare fields
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system for treatment of central nervous system disorders; central nervous system stimulants
44 Medical consultations; clinical medical practice consultation; mobile healthcare and medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues, medical management and clinical guidance; medical testing services for diagnostic or treatment purpose
10 Medical devices for use in treating or diagnosing central nervous system disorders with integrated recorded operating system software, sold as a unit
42 Pharmaceutical research and development; medical research and testing services in the field of central nervous system research; clinical medical research and medical testing services in the field of central nervous system research; providing online non-downloadable software tools for diagnosing, managing, monitoring, assessing, measuring, controlling and examining psychiatric and neurological disorders and diseases
The mark consists of connecting white and red semi and full circles vertically aligned over the center of a red rounded edge square, all appearing on a white background.
The color(s) white and red is/are claimed as a feature of the mark.
Nov 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 27, 2023
Abandonment - No Use Statement Filed
Apr 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 14, 2023
Sou Extension 5 Granted
Apr 7, 2023
Sou Extension 5 Filed
Apr 14, 2023
Case Assigned To Intent To Use Paralegal
Apr 7, 2023
Sou Teas Extension Received
Oct 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2022
Sou Extension 4 Granted
Oct 18, 2022
Sou Extension 4 Filed
Oct 18, 2022
Sou Teas Extension Received
Apr 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2022
Sou Extension 3 Granted
Apr 5, 2022
Sou Extension 3 Filed
Apr 5, 2022
Sou Teas Extension Received
Apr 4, 2022
Teas Change Of Correspondence Received
Apr 4, 2022
Teas Withdrawal As Domestic Representative Received
Apr 4, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 21, 2021
Sou Extension 2 Granted
Sep 21, 2021
Sou Extension 2 Filed
Sep 21, 2021
Sou Teas Extension Received
Mar 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 17, 2021
Sou Extension 1 Granted
Mar 17, 2021
Sou Extension 1 Filed
Mar 17, 2021
Sou Teas Extension Received
Oct 27, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 1, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 1, 2020
Published For Opposition
Aug 12, 2020
Notification Of Notice Of Publication E-Mailed
Jul 27, 2020
Law Office Publication Review Completed
Jul 20, 2020
Assigned To Lie
Jul 15, 2020
Approved For Pub - Principal Register
Jul 10, 2020
Examiner's Amendment Entered
Jul 10, 2020
Notification Of Examiners Amendment E-Mailed
Jul 10, 2020
Examiners Amendment E-Mailed
Jul 10, 2020
Examiners Amendment -Written
Jul 10, 2020
Examiners Amendment -Written
Jul 6, 2020
Previous Allowance Count Withdrawn
Jun 9, 2020
Withdrawn From Pub - Og Review Query
May 28, 2020
Approved For Pub - Principal Register
May 27, 2020
Examiner's Amendment Entered
May 27, 2020
Notification Of Examiners Amendment E-Mailed
May 27, 2020
Examiners Amendment E-Mailed
May 27, 2020
Examiners Amendment -Written
May 7, 2020
Teas/Email Correspondence Entered
May 7, 2020
Correspondence Received In Law Office
May 7, 2020
Teas Request For Reconsideration Received
Jan 9, 2020
Notification Of Final Refusal Emailed
Jan 9, 2020
Final Refusal E-Mailed
Jan 9, 2020
Final Refusal Written
Dec 3, 2019
Teas/Email Correspondence Entered
Dec 3, 2019
Correspondence Received In Law Office
Dec 3, 2019
Teas Response To Office Action Received
Jun 6, 2019
Notification Of Non-Final Action E-Mailed
Jun 6, 2019
Non-Final Action E-Mailed
Jun 6, 2019
Non-Final Action Written
May 30, 2019
Assigned To Examiner
Apr 9, 2019
Notice Of Design Search Code E-Mailed
Apr 6, 2019
New Application Office Supplied Data Entered
Mar 22, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
